Left Atrial Appendage Closure Devices Market Size By Product (Endocardial LAA Devices, Epicardial LAA Devices), By Procedure (Percutaneous, Surgical), By End-use (Hospitals, Ambulatory Surgical Centres), Industry Analysis Report, Regional Outlook, Growth

Left Atrial Appendage Closure Devices Market Size By Product (Endocardial LAA Devices, Epicardial LAA Devices), By Procedure (Percutaneous, Surgical), By End-use (Hospitals, Ambulatory Surgical Centres), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

Technological advancements and rising prevalence of AF (atrial fibrillation) will boost the left atrial appendage closure devices market growth during the forthcoming time period. The LAA (left atrial appendage) is a small sac that is shaped like an ear and is present inside the muscle wall of the left atrium in the heart. When it comes to hearts that are normal, the heart usually contracts with the heartbeats, and the blood in LAA and the left atrium is pushed into the left ventricle out of the left atrium.

In the case of AF (atrial fibrillation) in patients, the electrical impulses which are responsible for controlling the heartbeat are not able to travel in the usual manner through the heart. Rather, various impulses start simultaneously and thereby starts spreading through the atria. The chaotic and fast impulses do not give enough time to adequately squeeze blood into the ventricles.

Since the left atrial appendage is a small pouch, blood gets collected there, and could possibly form clots in the atria and LAA. This could further cause stroke when the blood clots are driven out of the heart. As a result, people having AF are usually more prone to have a stroke than the others.

Numerous devices have been proposed and tested for the safety and efficacy to treat this ailment. The devices which have been most studied are the WATCHMAN device, the LARIAT device, the PLAATO system, and the Amplatzer Cardiac Plug. These devices were normally implanted by using endovascular techniques, requiring a minimum skin incision. The WATCHMAN device is a self-expanding device usually the parachute-shaped which closes the LAA and has been approved by the FDA.

The left atrial appendage closure devices market is bifurcated in terms of product, procedure, end-use, and regional landscape.

Based on product, the LAA closure devices market is classified into epicardial LAA closure devices and endocardial LAA closure devices. Epicardial LAA closure devices segment is projected to expand at around 26.4% over the forecast time period.

With respect to procedure, the LAA closure devices market is categorized into surgical procedure and percutaneous procedure. Among these, the surgical procedure segment is expected to grow at around 27% through the analysis period.

In terms of end-use, the overall LAA closure devices market is segmented into ambulatory surgery centers, hospitals, and others. Ambulatory surgical centers segment was valued at around $92 million in 2019 and will continue to show appreciative growth.

From a regional frame of reference, Latin America LAA closure devices market was valued at more than $9.1 million in 2019 and is projected to grow at more than 24% over the forecast time period. MEA LAA closure devices market was valued at more than $7.5 million 2019 and is estimated to expand at a CAGR of more than 23% over the forecast time period.